1. Home
  2. PD vs PTGX Comparison

PD vs PTGX Comparison

Compare PD & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PagerDuty Inc.

PD

PagerDuty Inc.

HOLD

Current Price

$9.28

Market Cap

782.0M

Sector

Technology

ML Signal

HOLD

Logo Protagonist Therapeutics Inc.

PTGX

Protagonist Therapeutics Inc.

HOLD

Current Price

$97.01

Market Cap

6.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PD
PTGX
Founded
2009
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
782.0M
6.4B
IPO Year
2019
2016

Fundamental Metrics

Financial Performance
Metric
PD
PTGX
Price
$9.28
$97.01
Analyst Decision
Buy
Strong Buy
Analyst Count
9
13
Target Price
$12.63
$108.23
AVG Volume (30 Days)
2.1M
462.9K
Earning Date
05-28-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
416.95
N/A
EPS
0.13
0.05
Revenue
$492,546,000.00
N/A
Revenue This Year
$3.58
$874.25
Revenue Next Year
$2.88
N/A
P/E Ratio
$73.08
$2,055.80
Revenue Growth
5.36
N/A
52 Week Low
$5.70
$49.86
52 Week High
$17.45
$107.84

Technical Indicators

Market Signals
Indicator
PD
PTGX
Relative Strength Index (RSI) 63.25 47.17
Support Level $6.08 $96.36
Resistance Level $16.60 $104.85
Average True Range (ATR) 0.55 4.25
MACD 0.22 -0.26
Stochastic Oscillator 65.73 42.59

Price Performance

Historical Comparison
PD
PTGX

About PD PagerDuty Inc.

PagerDuty Inc is a digital operations management platform that manages urgent and mission-critical work for a modern, digital business. Its PagerDuty Operations Cloud combines artificial intelligence (AI) operations (AIOps), automation, customer service operations, and incident management with a generative AI assistant to create a flexible, resilient, and scalable platform to protect revenue and improve customer experience, improve operational efficiency, and mitigate the risk of operational failures. The company generates revenue predominantly from cloud-hosted software subscription fees and term-license software subscription fees. Geographically, the company derives a majority of its revenue from the United States and the rest from International markets.

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.

Share on Social Networks: